173 related articles for article (PubMed ID: 33782863)
1. Small Molecule Rescue of ATXN3 Toxicity in C. elegans via TFEB/HLH-30.
Fardghassemi Y; Maios C; Parker JA
Neurotherapeutics; 2021 Apr; 18(2):1151-1165. PubMed ID: 33782863
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of FKH-2/FOXG1 is neuroprotective in a C. elegans model of Machado-Joseph disease.
Fardghassemi Y; Parker JA
Exp Neurol; 2021 Mar; 337():113544. PubMed ID: 33290777
[TBL] [Abstract][Full Text] [Related]
3. Rescue of ATXN3 neuronal toxicity in
Fardghassemi Y; Tauffenberger A; Gosselin S; Parker JA
Dis Model Mech; 2017 Dec; 10(12):1465-1480. PubMed ID: 29061563
[TBL] [Abstract][Full Text] [Related]
4. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics.
Paulino R; Nóbrega C
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108570
[TBL] [Abstract][Full Text] [Related]
5. Functional genomics and biochemical characterization of the C. elegans orthologue of the Machado-Joseph disease protein ataxin-3.
Rodrigues AJ; Coppola G; Santos C; Costa Mdo C; Ailion M; Sequeiros J; Geschwind DH; Maciel P
FASEB J; 2007 Apr; 21(4):1126-36. PubMed ID: 17234717
[TBL] [Abstract][Full Text] [Related]
6. Identification of the 5-HT
Pereira-Sousa J; Ferreira-Lomba B; Bellver-Sanchis A; Vilasboas-Campos D; Fernandes JH; Costa MD; Varney MA; Newman-Tancredi A; Maciel P; Teixeira-Castro A
Neurobiol Dis; 2021 May; 152():105278. PubMed ID: 33516872
[TBL] [Abstract][Full Text] [Related]
7. Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein.
Ashraf NS; Sutton JR; Yang Y; Ranxhi B; Libohova K; Shaw ED; Barget AJ; Todi SV; Paulson HL; Costa MDC
Neurobiol Dis; 2020 Apr; 137():104697. PubMed ID: 31783119
[TBL] [Abstract][Full Text] [Related]
8. The TFEB orthologue HLH-30 regulates autophagy and modulates longevity in Caenorhabditis elegans.
Lapierre LR; De Magalhaes Filho CD; McQuary PR; Chu CC; Visvikis O; Chang JT; Gelino S; Ong B; Davis AE; Irazoqui JE; Dillin A; Hansen M
Nat Commun; 2013; 4():2267. PubMed ID: 23925298
[TBL] [Abstract][Full Text] [Related]
9. Treatment with sodium butyrate induces autophagy resulting in therapeutic benefits for spinocerebellar ataxia type 3.
Watchon M; Robinson KJ; Luu L; An Y; Yuan KC; Plenderleith SK; Cheng F; Don EK; Nicholson GA; Lee A; Laird AS
FASEB J; 2024 Jan; 38(2):e23429. PubMed ID: 38258931
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Export Inhibition Enhances HLH-30/TFEB Activity, Autophagy, and Lifespan.
Silvestrini MJ; Johnson JR; Kumar AV; Thakurta TG; Blais K; Neill ZA; Marion SW; St Amand V; Reenan RA; Lapierre LR
Cell Rep; 2018 May; 23(7):1915-1921. PubMed ID: 29768192
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease.
Duarte-Silva S; Silva-Fernandes A; Neves-Carvalho A; Soares-Cunha C; Teixeira-Castro A; Maciel P
Neuroscience; 2016 Jan; 313():162-73. PubMed ID: 26601773
[TBL] [Abstract][Full Text] [Related]
12. The deubiquitinase function of ataxin-3 and its role in the pathogenesis of Machado-Joseph disease and other diseases.
Potapenko A; Davidson JM; Lee A; Laird AS
Biochem J; 2024 Mar; 481(6):461-480. PubMed ID: 38497605
[TBL] [Abstract][Full Text] [Related]
13. HLH-30/TFEB Is a Master Regulator of Reproductive Quiescence.
Gerisch B; Tharyan RG; Mak J; Denzel SI; Popkes-van Oepen T; Henn N; Antebi A
Dev Cell; 2020 May; 53(3):316-329.e5. PubMed ID: 32302543
[TBL] [Abstract][Full Text] [Related]
14. Neuronal HLH-30/TFEB modulates peripheral mitochondrial fragmentation to improve thermoresistance in Caenorhabditis elegans.
Wong SQ; Ryan CJ; Bonal DM; Mills J; Lapierre LR
Aging Cell; 2023 Mar; 22(3):e13741. PubMed ID: 36419219
[TBL] [Abstract][Full Text] [Related]
15. Machado Joseph-Disease Is Rare in the Peruvian Population.
Cornejo-Olivas M; Solis-Ponce L; Araujo-Aliaga I; Milla-Neyra K; Ortega O; Illanes-Manrique M; Mazzetti P; Manrique-Enciso C; Cubas-Montecino D; Saraiva-Pereira ML; Jardim LB; Sarapura-Castro E
Cerebellum; 2023 Dec; 22(6):1192-1199. PubMed ID: 36323979
[TBL] [Abstract][Full Text] [Related]
16. Alteration of methylation status in the ATXN3 gene promoter region is linked to the SCA3/MJD.
Wang C; Peng H; Li J; Ding D; Chen Z; Long Z; Peng Y; Zhou X; Ye W; Li K; Xu Q; Ai S; Song C; Weng L; Qiu R; Xia K; Tang B; Jiang H
Neurobiol Aging; 2017 May; 53():192.e5-192.e10. PubMed ID: 28094059
[TBL] [Abstract][Full Text] [Related]
17. Selective forces acting on spinocerebellar ataxia type 3/Machado-Joseph disease recurrency: A systematic review and meta-analysis.
Sena LS; Dos Santos Pinheiro J; Saraiva-Pereira ML; Jardim LB
Clin Genet; 2021 Mar; 99(3):347-358. PubMed ID: 33219521
[TBL] [Abstract][Full Text] [Related]
18. Recent therapeutic prospects for Machado-Joseph disease.
Costa MDC
Curr Opin Neurol; 2020 Aug; 33(4):519-526. PubMed ID: 32657894
[TBL] [Abstract][Full Text] [Related]
19. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
[TBL] [Abstract][Full Text] [Related]
20. Toward understanding Machado-Joseph disease.
Costa Mdo C; Paulson HL
Prog Neurobiol; 2012 May; 97(2):239-57. PubMed ID: 22133674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
